Log in to search using one of your social media accounts:

 

Adding Anti-MRSA to Cephalexin No Better for Simple Cellulitis Adding Anti-MRSA to Cephalexin No Better for Simple Cellulitis
Cephalexin plus trimethoprim-sulfamethoxazole yielded no better clinical cure rates than cephalexin monotherapy, a new study has found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 24, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Adding TMP/SMX to Cephalexin May Not Boost Cure Rate in Uncomplicated Cellulitis (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM For patients with uncomplicated cellulitis, adding trimethoprim-sulfamethoxazole (TMP/SMX) to cephalexin may offer no benefit beyond cephalexin alone, a JAMA study finds.Some 500 patients older than 12 years seen in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 24, 2017 Category: Primary Care Source Type: news

Stress may protect, at least in bacteria
Antibiotics harm bacteria and stress them. Trimethoprim, an antibiotic, inhibits the growth of the bacterium Escherichia coli and induces a stress response. This response also protects the bacterium from subsequent deadly damage from acid. Antibiotics can therefore increase the survival chances of bacteria under certain conditions. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 23, 2017 Category: Science Source Type: news

Stress may protect -- at least in bacteria
(Institute of Science and Technology Austria) Antibiotics harm bacteria and stress them. Trimethoprim, an antibiotic, inhibits the growth of the bacterium Escherichia coli and induces a stress response. This response also protects the bacterium from subsequent deadly damage from acid. Antibiotics can therefore increase the survival chances of bacteria under certain conditions. This is shown in a study by researchers at IST Austria (Karin Mitosch, Georg Rieckh and Tobias Bollenbach), which was published in the journal Cell Systems. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2017 Category: Global & Universal Source Type: news

Relapses Common with S. Aureus Nasal Carriage in ANCA-Related Vasculitis (CME/CE)
(MedPage Today) -- Trimethoprim/sulfamethoxazole prophylaxis had no influence on relapse rate (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 6, 2017 Category: Rheumatology Source Type: news

Sulfatrim (Sulfamethoxazole and Trimethoprim Oral Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 1, 2017 Category: Drugs & Pharmacology Source Type: news

Bactrim (Trimethoprim and Sulfamethoxazole) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 25, 2016 Category: Drugs & Pharmacology Source Type: news

Trimethoprim (Trimethoprim Tablet) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 25, 2016 Category: Drugs & Pharmacology Source Type: news

Primsol (trimethoprim)
Title: Primsol (trimethoprim)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/18/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - November 18, 2016 Category: Drugs & Pharmacology Source Type: news

polymyxin B sulfate and trimethoprim (Polytrim)
Title: polymyxin B sulfate and trimethoprim (Polytrim)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 7/11/2016 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 11, 2016 Category: Opthalmology Source Type: news

Primsol (Trimethoprim Hydrochloride Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 6, 2016 Category: Drugs & Pharmacology Source Type: news

trimethoprim, Trimpex (Discontinued Brand), Proloprim (Discontinued Brand), Primsol
Title: trimethoprim, Trimpex (Discontinued Brand), Proloprim (Discontinued Brand), PrimsolCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/29/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 29, 2016 Category: Drugs & Pharmacology Source Type: news

Make the Diagnosis: Blistering Mystery
(MedPage Today) -- Case Findings: A 34-year-old woman was brought to urgent care by her husband. She had a widespread dusky red rash that was beginning to blister. During her intake, the nurse noted the patient had recently been prescribed trimethoprim-sulfamethoxazole for a urinary tract infection. When the doctor put pressure on a lesion, he observed Nikolskys sign. The patient also complained of mouth pain and a sore throat, and the doctor could observe lesions forming on her mucosal lip. What is your diagnosis? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 22, 2016 Category: Dermatology Source Type: news

Common antibiotic for children 'ineffective in half of cases'
Conclusion This is an important study that may mean doctors need to change the way they treat one of the most common childhood illnesses. Because urine infections can be painful and can damage the kidneys in young children, it's important they are treated quickly and effectively. Current guidelines for doctors, which were published nine years ago, say children over three months of age with urine infections should be treated for three days with an antibiotic "directed by locally developed guidance", which might include trimethoprim, nitrofurantoin, cephalosporin or amoxicillin. Only if the antibiotic does not w...
Source: NHS News Feed - March 16, 2016 Category: Consumer Health News Tags: Medication Pregnancy/child Source Type: news

TMP-SMX Resistance in Pediatric Recurrent UTIs Higher after Prophylaxis but Declines Over Time (FREE)
By Christine Judge Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH Prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) in children with symptomatic urinary tract infection (UTI) and vesicoureteral reflux is associated with higher incidence of TMP-SMX resistance in recurrent infections but not … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 14, 2016 Category: Primary Care Source Type: news

Better way to treat abscesses: Add antibiotic to conventional approach
UCLA researchers have found that doctors can use a specific antibiotic in addition to surgically draining an abscess to give people a better chance of recovery. The discovery turns on its head the long-held notion that surgical drainage alone is sufficient for treating abscesses. The findings are particularly important because of the emergence of community-acquired methicillin-resistant Staphylococcus aureus, or MRSA, which since 2000 has become the most common cause of skin infections — initially in the U.S. and now in many other parts of the world. The UCLA study will be published March 3 by the New England Journal...
Source: UCLA Newsroom: Health Sciences - March 3, 2016 Category: Universities & Medical Training Source Type: news

Skin Abscess Outcomes Improve With Antibiotics PostdrainageSkin Abscess Outcomes Improve With Antibiotics Postdrainage
Adjunctive trimethoprim-sulfamethoxazole led to higher cure rates than drainage alone in a randomized trial of patients with uncomplicated skin abscesses treated in the emergency department. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 3, 2016 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Aytu BioScience Obtains CE Marking for Company's MiOXSYS(TM) System for Male Infertility
Regulatory Clearance Enables Commercialization in Europe and other Key Markets ENGLEWOOD, Colo., Jan. 12, 2016 -- (Healthcare Sales & Marketing Network) -- Aytu BioScience, Inc. (AYTU), a specialty healthcare company focused on commercializing treatmen... Biopharmaceuticals, Urology, RegulatoryAytu BioScience, MiOXSYS, ProstaScint, Primsol, trimethoprim (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2016 Category: Pharmaceuticals Source Type: news

Limited Access to Pyrimethamine Prompts Update of Toxoplasmosis Section of the Adult and Adolescent OI Guidelines
The Toxoplasma gondii Encephalitis section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents has been updated to provide clinicians with guidance on the use of trimethoprim-sulfamethoxazole for treatment of acute infection and chronic maintenance therapy for suspected or documented toxoplasmosis if pyrimethamine is not readily available.   On September 10, 2015, the OI Guidelines author panel issued this Notice of Availability of Pyrimethamine, which is guidance on what to do if pyrimethamine is unavailable to treat or prevent Toxoplasma encephalitis,...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 19, 2015 Category: Infectious Diseases Source Type: news

Availability of Pyrimethamine: Statement from Adult & Adolescent OI Guideline Panel
Pyrimethamine is recommended for treatment and/or prophylaxis of Toxoplasma encephalitis, Pneumocystis pneumonia, and Isospora infection. As of June 2015, pyrimethamine is no longer available in retail pharmacies in the United States. It is only available through a special pharmacy program (http://www.daraprimdirect.com/how-to-prescribe). If there is a delay in procuring pyrimethamine for a patient in whom it is needed for one of the above indications, please refer to the specific pathogen section for alternative drug regimens for treatment or prophylaxis. For patients with suspected or documented toxoplasmosis who do not ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news

Darunavir and Trimethoprim-Sulfamethoxazole Cross-ReactivityDarunavir and Trimethoprim-Sulfamethoxazole Cross-Reactivity
This study examines the cross-reactivity between both drugs. AIDS (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 25, 2015 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Scientists 'amazed' at spread of typhoid 'superbug'
ConclusionThis study has provided information about the spread of a strain of typhoid called H58, which is commonly antibiotic-resistant, by looking at the genetics of samples collected between 1903 and 2013. It has shown that the strain was likely to have arisen in South Asia and then spread to Southeast Asia and Africa. The strain showed different patterns of antibiotic resistance in different regions – likely driven by different patterns in the use of antibiotics. While this study has not estimated the number of cases or deaths worldwide attributable to this strain specifically, there are reported to be 20-30 mill...
Source: NHS News Feed - May 12, 2015 Category: Consumer Health News Tags: Medical practice Source Type: news

Two Popular Antibiotics Equally Effective in Skin InfectionsTwo Popular Antibiotics Equally Effective in Skin Infections
The popular antibiotics clindamycin and trimethoprim-sulfamethoxazole are essentially equivalent in treating outpatients with uncomplicated skin infections, according to a randomized controlled trial. Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 19, 2015 Category: Dermatology Tags: Infectious Diseases News Source Type: news

TMP-SMX and Clindamycin Offer Similar Efficacy for Uncomplicated Skin Infections (FREE)
By Larry M. Baddour, MD Trimethoprim-sulfamethoxazole (TMP-SMX) and clindamycin lead to similar cure rates in patients with uncomplicated skin infections, according to a New England Journal of Medicine study.Researchers enrolled some 500 outpatients (mean age, 27) with cellulitis, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 19, 2015 Category: Primary Care Source Type: news

Choosing An Antibiotic For Skin Infections--What's Best?
A new study in the New England Journal of Medicine on treatment of skin infections compares treatment with trimethoprim sulfamethoxazole (TMP-SMX, Bactrim or Septra) or clindamycin. Surprisingly, both worked equally well in this 524 patient study, curing about 89% of outpatients with uncomplicated skin infections cellulitis and abscesses, so the authors appear to encourage use of one of these drugs because they are better at treating MRSA than are currently recommended antibiotics. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2015 Category: Pharmaceuticals Authors: Judy Stone Source Type: news

Clindamycin, TMP-SMX are equally effective for skin infections
Clindamycin and trimethoprim-sulfamethoxazole are similarly safe and effective for treating uncomplicated skin infections, including both cellulitis and abscesses, in ambulatory settings in regions where MRSA is endemic, according to a report published online March 19 in the New England Journal of... (Source: Skin and Allergy News)
Source: Skin and Allergy News - March 18, 2015 Category: Dermatology Tags: CME-candidate EM Journals EM Clinical News EM News EM Dermatology EM Infectious Disease FPN Journals FPN News Source Type: news

Two commonly used antibiotics have similar cure rates for uncomplicated skin infections
(Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)) Two antibiotics frequently prescribed to treat serious skin infections -- clindamycin and trimethoprim sulfamethoxazole (TMP-SMX) -- had similar rates of success in curing uncomplicated infections in outpatients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 18, 2015 Category: Infectious Diseases Source Type: news

Antibiotic, Spironolactone Combo Ups Sudden Death in Elderly Antibiotic, Spironolactone Combo Ups Sudden Death in Elderly
When combined with spironolactone, a diuretic, trimethoprim-sulfamethoxazole is riskier than other antibiotics in people older than 65 years. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 3, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Commonly used antibiotics with diuretic can double risk of sudden death in older patients
The combination of the commonly prescribed antibiotic trimethoprim-sulfamethoxazole with the diuretic spironolactone, widely used for heart failure, more than doubles the risk of death for older patients, reports a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 2, 2015 Category: Science Source Type: news

Certain Heart Drug, Antibiotic Combo Might Be Fatal for Seniors
Doctors should not prescribe spironolactone with trimethoprim-sulfamethoxazole, study saysSource: HealthDay Related MedlinePlus Pages: Drug Reactions, Medicines, Seniors' Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 2, 2015 Category: Consumer Health News Source Type: news

trimethoprim, Trimpex (Discontinued Brand), Proloprim (Discontinued Brand), Primsol
Title: trimethoprim, Trimpex (Discontinued Brand), Proloprim (Discontinued Brand), PrimsolCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/28/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - January 28, 2015 Category: Drugs & Pharmacology Source Type: news

Concomitant Use of TMP-SMX and Common BP Drugs Linked to Sudden Death (FREE)
By Amy Orciari Herman Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Among older patients taking angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), concomitant use of the antibiotic trimethoprim-sulfamethoxazole is associated with increased risk for sudden death, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 31, 2014 Category: Primary Care Source Type: news

polymyxin B sulfate and trimethoprim (Polytrim)
Title: polymyxin B sulfate and trimethoprim (Polytrim)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 10/24/2014 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - October 24, 2014 Category: Opthalmology Source Type: news

Antibiotic treatments 'fail' 15% of the time
ConclusionOverall, this is a highly informative study of GP antibiotic prescribing for common infections in the UK. The overall antibiotic treatment failure rate was 15% over the course of the study period; these were mainly cases where there was a need to prescribe a different antibiotic within 30 days. There was a slight increase in failure rate, from 13.9% in 1991 to 15.4% in 2012. Within the infection classes, particular antibiotics had notable changes in failure rates, while others remained fairly stable. Reassuringly, amoxicillin and other commonly prescribed antibiotics currently still have fairly low failure rates....
Source: NHS News Feed - September 26, 2014 Category: Consumer Health News Tags: Medication Medical practice Source Type: news

Steep rise in antibiotic use for coughs and colds
ConclusionThis cross-sectional study has found the proportion of people with coughs and colds that are prescribed antibiotics rose from 36% in 1999 to 51% in 2011 – an increase of approximately 40%. This is despite the publication of guidance recommending that GPs do not prescribe antibiotics for coughs and colds. It also found substantial variation between different GP practices, with 10% of practices prescribing antibiotics for less than 32% of cases and 10% of practices prescribing antibiotics for more than 65% of cases, suggesting that substantially lower rates of prescribing could be achieved.The ...
Source: NHS News Feed - August 5, 2014 Category: Consumer Health News Tags: Medical practice Medication Source Type: news

What Medications Should Be Avoided with Long QT Syndrome?
Discussion Mycoplasma pneumoniae is a frequent cause of pharyngitis, pneumonia and acute bronchitis, but acute otitis media is uncommon. Symptoms are usually self-limited and variable and include cough (non-productive usually but later can be productive), fever, fatigue and occasionally headache. Coryza is rare. Cough can continue for 3 to 4 weeks and can be accompanied by wheezing. Radiographic changes include diffuse infiltrates or focal abnormalities but are variable. Long QT syndrome (LQTS) is a group of disorders that have a prolonged QT interval and a polymorphic ventricular tachycardia. Torsade de pointes (“t...
Source: PediatricEducation.org - July 14, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Global Trimethoprim Sulfate Industry Examined by 9Dimen Research in...
In-demand research study, “2014 Market Research Report on Global Trimethoprim Sulfate Industry,” worked out by 9Dimen Research is now available at MarketPublishers.com.(PRWeb July 01, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb11985992.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 1, 2014 Category: Pharmaceuticals Source Type: news

Abandoned antibiotic makes a comeback
Scarlet fever and infections of the skin and throat are often caused by a bacterium called Streptococcus pyogenes. In less-developed countries, inexpensive and well-tolerated antibiotics for therapy are often not available. Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, have discovered that trimethoprim may provide an option. Contrary to a long-held belief, the bacteria are not generally resistant to this agent. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 21, 2014 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Comeback of an abandoned antibiotic: Trimethoprim
In less-developed countries, inexpensive and well-tolerated antibiotics for therapy of streptococcal infections are often not available. Scientists have discovered that trimethoprim may provide an option. Contrary to a long-held belief, the bacteria are not generally resistant to this agent. In their latest publication the scientists demonstrated three pathways for the development of resistance -- meaning that streptococci can easily become resistant to the antibiotic and pass on this trait quickly. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 19, 2014 Category: Science Source Type: news

Comeback of an abandoned antibiotic
(Helmholtz Centre for Infection Research) In less-developed countries, inexpensive and well-tolerated antibiotics for therapy of streptococcal infections are often not available. Scientists of the HZI in Germany have discovered that trimethoprim may provide an option. Contrary to a long-held belief, the bacteria are not generally resistant to this agent. In their latest publication the scientists demonstrated three pathways for the development of resistance -- meaning that streptococci can easily become resistant to the antibiotic and pass on this trait quickly. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 19, 2014 Category: Infectious Diseases Source Type: news

Doctors issue new treatment guidelines for skin abscesses caused by MRSA
It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent this virulent form of staph infection, which is immune to many antibiotics.   As MRSA cases have increased dramatically over the decade, so have the number of skin abscesses — generally pus-filled boils or pimples with discharge — that characterize these infections. Now, researchers from UCLA have issued updated guidelines outlining the best ways to treat and manage these abscesses.   The ...
Source: UCLA Newsroom: Health Sciences - March 12, 2014 Category: Universities & Medical Training Source Type: news

Doctors issue new treatment guidelines for skin abscesses caused by MRSA
It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent this virulent form of staph infection, which is immune to many antibiotics. As MRSA cases have increased dramatically over the decade, so have the number of skin abscesses — generally pus-filled boils or pimples with discharge — that characterize these infections. Now, researchers from UCLA have issued updated guidelines outlining the best ways to treat and manage these abscesses. The first cas...
Source: UCLA Newsroom: Health Sciences - March 12, 2014 Category: Universities & Medical Training Source Type: news

TMP-SMX Prevents Ocular Toxoplasmosis RecurrenceTMP-SMX Prevents Ocular Toxoplasmosis Recurrence
Extended treatment with trimethoprim-sulfamethoxazole may reduce the risk of recurrence in patients with Toxoplasma gondii retinochoroiditis (TGR), according to a new study of 95 patients. Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - January 27, 2014 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Treatment of Infections Due to Resistant Staphylococcus aureus
This chapter reviews data on the treatment of infections caused by drug-resistant Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA). This review covers findings reported in the English language medical literature up to January of 2013. Despite the emergence of resistant and multidrug-resistant S. aureus, we have seven effective drugs in clinical use for which little resistance has been observed: vancomycin, quinupristin–dalfopristin, linezolid, tigecycline, telavancin, ceftaroline, and daptomycin. However, vancomycin is less effective for infections with MRSA isolates that have a higher MIC w...
Source: Springer protocols feed by Microbiology - October 6, 2013 Category: Microbiology Source Type: news

Screening Libraries for Improved Solubility: Using E. coli Dihydrofolate Reductase as a Reporter
Low protein solubility is a problem in many areas of protein science. Although chemical methods have been developed to solubilize proteins these are not always effective and add to the cost of producing the protein. One way of overcoming these difficulties is to evolve the protein to be more soluble. A major hurdle in this process is the ability to select mutant proteins with enhanced solubility from a large library of randomly mutated proteins. In this article, we describe such a method. The method relies on the fact that increasing the expression of dihydrofolate reductase (DHFR) makes Escherichia coli resistant to Trime...
Source: Springer protocols feed by Biochemistry - February 21, 2013 Category: Biochemistry Source Type: news

NICE publishes QIPP Medicines Management document
Source: NICE Area: News NICE has published an evidence based document summarising medicines management options for local implementation on identified topics supporting the QIPP medicines use and procurement work stream. The document, which is not formal NICE guidance, covers the following identified topics:   . Laxatives . Renin-angiotensin system drugs . Lipid modifying drugs including ezetimibe . Omega-3 fatty acid supplements . High dose inhaled corticosteroids in asthma . Hypnotics . Low dose antipsychotics in people with dementia . First-choice antidepres...
Source: NeLM - News - February 1, 2013 Category: Drugs & Pharmacology Source Type: news

Could Renal Abscess Be a Complication of Pyelonephritis in this Patient?
Discussion Urinary tract infections (UTI) are common. By the age of 7 years up to 8% of girls and 2% of boys have had a UTI. The current American Academy of Pediatrics criteria for a UTI diagnosis includes presence of pyruria (determined by microscopy) or leucocyte esterase (on dipstick) AND a culture-positive urine of 100,000 colony-forming units on a voided specimen. Because of possible contamination, bagged specimens are not acceptable. Clinical pyelonephritis (ie febrile UTI) is a fairly common problem in the pediatric population. Learning Point Renal abscesses are uncommon with the exact incidence unknown and are defi...
Source: PediatricEducation.org - January 14, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

Cholera and Diarrhea
CHOLERA and DIARRHEA At this very moment there is an outbreak of cholera in Zimbabwe– not a worldwide pandemic, but a localized epidemic. This is not a trivial point of interest, but a major news event that will not only have a dramatic impact on the population of Zimbabwe but also on the entire world as the aftermath of this epidemic will require international aid. Cholera will most likely kill thousands of people in Zimbabwe, impact tens of thousands of lives, and will continue to be a constant threat around the world and a very real concern for the adventurous and international travelers. What is cholera? Cholera...
Source: Wilderness Medicine Newsletter - January 1, 2009 Category: Rural Health Authors: wildernessmedicinenewsletter Tags: Cholera Diarrhea Source Type: news